Globus Medical of Audobon and San Diego-based NuVasive have completed their multibillion-dollar merger that unites the two medical device companies.
Under the terms of the all-stock deal valued at about $3 billion, Globus (NYSE: GMED) will issue 0.75 shares of its Class A common stock in exchange for each share of NuVasive common stock owned at the closing of the transaction.
NuVasive shares ceased trading on the Nasdaq as of the close of trading on Aug. 31.
Shares of Globus were trading down…
